Author Guidelines and Online Submission


Journal of Media Medika Indonesiana (M Med Indones) provides high quality research in all areas of biomedical and clinical sciences. The Journal publishes articles on a wide range of subjects of interest to researchers and clinical practitioners.

In addition to research articles, the journal welcomes submission of reviews, perspectives, case reports, and brief communications.

Research areas include but are not limited to: general medicine, clinical medicine, molecular medicine, tropical medicine, infectious diseases, cardiovascular medicine, molecular biology, genetics, immunology, biochemistry,pathogenesis, epidemiology, diagnosis, biomedical science, monitoring and treatment protocols

The journal considers for publication manuscripts prepared in accordance with the Guidelines for the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see N Engl J Med 1997; 336: 309–315).

Editorial policy

The Journal aims to publish high quality research in the general areas of biomedicine and clinical researches. Acceptance of papers for publication in the Journal is at the discretion of the Editors. The Journal reserves the right to allocate manuscripts to the most appropriate Editors will seek advice from two or more expert reviewers about the scientific content, significance, and clarity of presentation of papers. The review process will take approximately four weeks from the date of submission. Manuscripts are received with the understanding that they have not been published or are not under consideration for publication elsewhere. Manuscripts are accepted based on the recommendations of the referees. Published papers become the sole property of M Med Indones and will be copyrighted by M Med Indones.

Types of paper

The Journal will publish research article, review, perspective, case report, brief communication and letter to the editor.

  • Research article should normally be 15 printed pages or less with no more than 10 figures and four tables.
  • Reviews are scholarly and balanced accounts of progress in fields of interest to the general reader. Reviews should be no longer than 12 printed pages and with no more than 12 figures and tables. Authorship is normally by invitation: an Editor should be consulted in advance by anyone wishing to submit an unsolicited Review.
  • Short articles / brief communication / case reports are brief papers that communicate a specific well-documented point. In general, a communication should include no more than four figures and tables.
  • Perspectives are brief reviews that present a sharply focused view of a rapidly advancing area of research. Authorship is normally by invitation: an Editor should be consulted in advance by anyone wishing to submit an unsolicited Perspective.
  • Letter to the editor. Response to a specific article published by the Journal.

Authors are asked to suggest 5 expert referees. Where appropriate, authors should suggest 2 to 3 referees who are expert in the methodology as well as 2 to 3 referees who are expert on the clinical or biomedical field. Authors should avoid suggesting as referees people whom, within the past 3 years, they have had a collaborative relationship with, they have mentored, or who have mentored the authors. In rare instances, authors may also request that conflicted individuals be excluded from the review process. However, the editors reserve the right to choose as referees individuals who in their opinion are best qualified to review the paper.

A PDF file comprising all text and figures is acceptable for initial submission. When submitting a revised manuscript, separate electronic files are required. Each manuscript is to be accompanied by an electronic cover letter outlining the basic findings of the paper and their significance. PDFs of all related manuscripts under consideration for publication must also be included with the submitted manuscript.



When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 ( Do not use patients' names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on the care and use of laboratory animals was followed.


When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Report losses to observation (such as dropouts from a clinical trial). Put a general description of methods in the Methods section. When data are summarized in the Results section, specify the statistical methods used to analyse them. Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a randomising device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical terms, abbreviations, and most symbols.

Conflict of interest

All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.

Submission declaration

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

Before the accepted manuscript is published in an online issue:

Requests to add or remove an author, or to rearrange the author names, must be sent to the  from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Editor in Chief to the corresponding author, who must follow the procedure as described above. Note that: (1) Editor in Chief will inform the Managing Editor of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

After the accepted manuscript is published in an online issue:

Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.


Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'. Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a  'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

Language and language services

Please write your text in good English (American or British usage is accepted, but not a mixture of these).


Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.


Use of word processing software

It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.

Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.

To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your wordprocessor.

Article structure

Manuscripts should be submitted as a word processing file, with one inch margins and double spaced lines.


The conventions used in current issues of the Journal for headings, references etc. should be used in preparing manuscripts. Articles are divided into sections in the following order: Introduction; Materials and Methods; Results; Discussion.

Other section headings (e.g., Theory, Results and Discussion) may be used if this improves the clarity of presentation. Short articles / brief communication / case reports should not be divided into sections but should include topic headings where appropriate.

Essential title page information

  • Title. The title should convey the concept and the importance of the paper to non-specialist readers. Titles may occupy no more than three lines of type. Each line should contain no more than 50 characters, including spaces. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
  • Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
  • Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
  • Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes. All pages should be numbered serially.


The abstract must be concise (limit of 250 words) and factual. It should convey the concept and the importance of the paper to non-specialist readers. The abstract should state briefly the background of the question, the principal results and conclude on a clear description of the conceptual advance and significance of the work. Detailed descriptions of the study or of the findings should not be included in the abstract. An abstract is required for all papers. An abstract is often presented separately from the article, so must be able to stand alone. Also, nonstandard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.

Short running title

A short title will appear in the header of article. Maximum 5 words.


Authors should supply five keywords after the Abstract. Keywords should not be words from the title.


Define non-standard abbreviations in a footnote to be placed on the first page of the article. Abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.


State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

Materials and methods

Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.


Results should be clear and concise.


This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.

Database linking and Accession numbers

Elsevier aims at connecting online articles with external databases which are useful in their respective research communities. If your article contains relevant unique identifiers or accession numbers (bioinformatics) linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases, then please indicate those entities according to the standard explained below. Authors should explicitly mention the database abbreviation (as mentioned below) together with the actual database number, bearing in mind that an error in a letter or number can result in a dead link in the online version of the article. Please use the following format: Database ID: xxxx

Links can be provided in your online article to the following databases (examples of citations are given in parentheses):

  1. GenBank: Genetic sequence database at the National Center for Biotechnical Information (NCBI) (GenBank ID: BA123456)
  2. PDB: Worldwide Protein Data Bank (PDB ID: 1TUP)
  3.  CCDC: Cambridge Crystallographic Data Centre (CCDC ID: AI631510)
  4. TAIR: The Arabidopsis Information Resource database (TAIR ID: AT1G01020)
  5. NCT: (NCT ID: NCT00222573)
  6. OMIM: Online Mendelian Inheritance in Man (OMIM ID: 601240)
  7. MINT: Molecular INTeractions database (MINT ID: 6166710)
  8. MI: EMBL-EBI OLS Molecular Interaction Ontology (MI ID: 0218)
  9. UniProt: Universal Protein Resource Knowledgebase (UniProt ID: Q9H0H5)

Accession numbers

Accession numbers must be cited immediately following the Materials and Methods section. Accession numbers are unique identifiers in bioinformatics allocated to nucleotide and protein sequences to allow tracking of different versions of that sequence record and the associated sequence in a data repository [e.g., databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine ('GenBank') and the Worldwide Protein Data Bank]. There are different types of accession numbers in use based on the type of sequence cited, each of which uses a different coding. Authors should explicitly mention the type of accession number together with the actual number, bearing in mind that an error in a letter or number can result in a dead link in the online version of the article. Please use the following format: accession number type ID: xxxx (e.g., MMDB ID: 12345; PDB ID: 1TUP). Note that in the final version of the electronic copy, accession numbers will be linked to the appropriate database, enabling readers to go directly to that source from the article. For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. Example 1: "GenBank accession nos. AI631510 , AI631511 , AI632198 , and BF223228 , a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048 , and a T-cell lymphoma (GenBank accession no. AA361117 )".


Please supply, as a separate list, the definitions of field-specific terms used in your article.


Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).


Footnotes should be used sparingly. Designate them throughout the article, using an asterisk (*). Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.


Electronic artwork

General points

  • Make sure you use uniform lettering and sizing of your original artwork.
  • Save text in illustrations as 'graphics' or enclose the font.
  • Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
  • Number the illustrations according to their sequence in the text.
  • Use a logical naming convention for your artwork files.
  • Provide captions to illustrations separately.
  • Produce images near to the desired size of the printed version.
  • Submit each figure as a separate file.


Regardless of the application used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings,halftones, and line/halftone combinations given below):

  • EPS: Vector drawings. Embed the font or save the text as 'graphics'.
  • TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
  • TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
  • TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.

If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.

Please do not:

  • Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
  • Supply files that are too low in resolution;
  • Submit graphics that are disproportionately large for the content.

Composite figures. In general, no more than four sections should appear in a single figure. If more than four sections are required, it is better to create several separate figures. Label individual sections in composite figures clearly with lower case letters, using (a), (b), (c).

Stereo pairs. Stereo pairs should be in divergent (wall-eye) view and should be supplied at the same size as they are to appear in the Journal. Before submitting figures, authors should check carefully that stereo figures are correct and give the proper stereo image.

Color artwork

Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then, at no additional charge.

Figure captions

Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.


Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.


Citation in text

Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either "Unpublished results" or "Personal communication". Citation of a reference as "in press" implies that the item has been accepted for publication and a copy of the title page of the relevant article must be submitted.

Web references

As a minimum, the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Reference to material which is available on the Internet but has not been published elsewhere should be made in the text only and should not be included in the reference list.

Reference style

References should be listed at the end of the manuscript. They should be listed in the order in which they appear in the text, tables, and figure legends and numbered sequentially. When cited in the text, reference numbers should be superscripted. Only papers that have been published or accepted should be cited in the reference list. The title of the article, the volume number, and first and last pages should be cited. Journal titles should be abbreviated, e.g.,

  • Ehrlich JR, Nattel S. Novel approaches for pharmacological management of atrial fibrillation. Drugs. 2009;69(7):757-74.
  • Brundel BJ, Shiroshita-Takeshita A, Qi X, Yeh YH, Chartier D, van Gelder IC, et al. Induction of heat shock response protects the heart against atrial fibrillation. Circ Res. 2006; 99(12):1394-402. Articles in books should include the title of the article, the name of the book, editor(s), edition number, first and last page numbers, the name and the location of the publisher, e.g.,
  • Hanks SK, Hunter T. The eukaryotic protein kinase superfamily. In The Protein Kinase FactsBook: Protein-Serine Kinases (Hardie G, Hanks S, eds), 1995, pp. 747, Academic Press, London.

Journal abbreviations source

SI units and the system of abbreviations and symbols formulated by the IUPAC-IUB Combined Commission on Biochemical Nomenclature should be followed. When non-SI units are used, their equivalent SI units should be given. Genetic names should be described according to the appropriate conventions. Genus and species names should be written in full at first use and in italics (e.g., Escherichia coli, Caenorhabditis elegans).

Supplemental data

The acceptance of supplemental material is at the Editor's discretion. Supplemental information must be submitted with the manuscript for review by the editor and referees. Manuscripts must be complete and stand-alone. Supplemental material should complement the printed paper and may include figures and figure legends, tables, supporting data, sequence alignments, primers, derivation of equations, and videos. The availability of supplemental information will be indicated in the printed paper and the supplemental data will be directly linked to the online version of the paper. Reference to the supplemental information may be made at appropriate places in the text. With the exception of videos, the supplemental information must be submitted electronically in the form of a single PDF file. Very large tabulations of supporting data may be submitted as Microsoft Excel files.

Submission checklist

It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.

Ensure that the following items are present:

One Author designated as corresponding Author:

  • E-mail address
  • Full postal address
  • Telephone and fax numbers
  • All necessary files have been uploaded
  • Keywords
  • All figure captions
  •  All tables (including title, description, footnotes)

Further considerations

  • Manuscript has been "spellchecked" and "grammar-checked"
  • References are in the correct format for this journal
  • All references mentioned in the Reference list are cited in the text, and vice versa
  • Permission has been obtained for use of copyrighted material from other sources (including the Web)
  • Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
  • If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes



One set of page proofs (as doc or PDF files) will be sent by e-mail to the corresponding author or, a link will be provided in the e-mail so that authors can download the files themselves.

If you do not wish to use the doc or PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Journal office in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that M Med Indones may proceed with the publication of your article if no response is received.

Offprints and article-processing charges

Open access publishing is not without costs. M Med Indones therefore levies an article-processing charge of Rp500,000/$50 for each article accepted for publication. The corresponding author will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication.

It is important to note that M Med Indones operates a waiver policy to ensure that article-processing charges are not an obstacle for authors without sufficient funding. For authors from low per-capita income country which has a 2010 gross domestic product of less than 200 billion US dollars (reference - World Bank 1st December 2011), the charges are waived. Authors from other countries can request reductions and full waivers during the submission process, with decisions being made on a case-by-case basis, separate from and independent of the editorial process.


For inquiries relating to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.

Download Template